首页> 美国卫生研究院文献>Diabetes Metabolism Journal >Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study

【2h】

Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study

机译：在糖尿病性视网膜病变进展中二甲双胍单药治疗中二肽基肽酶-4抑制剂与其他抗糖尿病药的比较：基于真实世界的队列研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To investigate the effects of dipeptidyl peptidase-4 inhibitor (DPP4i) as add-on medications to metformin on progression of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus, compared with sulfonylurea (SU) or thiazolidinedione (TZD).

机译：与磺酰脲类药物（SU）或噻唑烷二酮（TZD）相比，研究二肽基肽酶-4抑制剂（DPP4i）作为二甲双胍的附加药物对2型糖尿病患者糖尿病性视网膜病变（DR）进展的影响。

著录项

期刊名称 Diabetes Metabolism Journal
作者
Yoo-Ri Chung; Kyoung Hwa Ha; Hyeon Chang Kim; Sang Jun Park; Kihwang Lee; Dae Jung Kim;
展开▼
作者单位

展开▼
年(卷),期 2019(43),5
年度 2019
页码 -1
总页数 9
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Diabetes mellitus; type 2; Diabetic retinopathy; Dipeptidyl-peptidase IV inhibitors;

机译：糖尿病;2型;糖尿病性视网膜病变;二肽基肽酶IV抑制剂;

相似文献

外文文献
中文文献
专利

1. Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study [J] . Gy?rgy Jermendy, Zoltán Kiss, Gy?rgy Rokszin, Diabetes therapy . 2018,第5期

机译：在2型糖尿病患者中持续使用新型抗糖尿病药物（二肽基肽酶4抑制剂，钠葡萄糖共转运蛋白2抑制剂和胰高血糖素样肽1受体激动剂）进行的全国性队列研究
2. Cardiovascular risks associated with dipeptidyl peptidase-4 inhibitors monotherapy compared with other antidiabetes drugs in the Japanese population: A nationwide cohort study [J] . Komamine Maki, Kajiyama Kazuhiro, Ishiguro Chieko, Pharmacoepidemiology and drug safety . 2019,第9期

机译：与二肽肽酶-4抑制剂相关的心血管风险与日本人群中的其他抗肽药物相比，与其他抗体药物相比：全国范围内的群组
3. The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study [J] . Gamble John-Michael, Donnan Jennifer R., Chibrikov Eugene, Diabetes research and clinical practice . 2018,第期

机译：与磺酰脲类和其他抗糖尿病药物相比，二肽肽酶-4抑制剂新用户的脆性骨折风险与其他抗糖尿病药物相比：队列研究
4. Fragment-Based Drug Design to Discover Novel Inhibitor of Dipeptidyl Peptidase-4 (DPP-4) as a Potential Drug for Type 2 Diabetes Therapy [C] . Eka Gunarti Ningsih, Muhammad Fauzi Hidayat, Usman Sumo Friend Tambunan International work-conference on bioinformatics and biomedical engineering . 2019

机译：基于片段的药物设计，发现二肽基肽酶-4（DPP-4）的新型抑制剂作为2型糖尿病治疗的潜在药物
5. Retrospective cohort study to determine the effect of metformin on survival of diabetic patients with pancreatic adenocarcinoma. [D] . Sadeghi, Navid. 2010

机译：回顾性队列研究确定二甲双胍对糖尿病胰腺癌患者生存的影响。
6. Letter: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8) [O] . Jun Sung Moon 2019

机译：信函：二甲双胍单药治疗中在糖尿病性视网膜病变进展中加入二肽基肽酶-4抑制剂与其他抗糖尿病药物的比较：基于现实世界的队列研究（Diabetes Metab J 2019; 43：640–8）
7. Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study [O] . Yoo-Ri Chung, Kyoung Hwa Ha, Hyeon Chang Kim, 2019

机译：二肽基肽酶-4抑制剂与其他抗糖尿病药物加入二甲双胍单疗法中，糖尿病视网膜病变进展：基于真正的世界队列研究

Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study

摘要

著录项

相似文献

相关主题

期刊订阅